| Cord Blood America's mission is to be the most respected stem cell preservation company in the world. Cord Blood America will achieve its mission through educating expectant parents, families with a history of disease, critically ill patients, and all others who wish to learn about this life saving opportunity. We will provide constant care and support to the families whose stem cells we preserve, and to the medical professionals who help them do so. We are joined in the fight to combat life-threatening illness by educating one person at a time.
Founded in summer 2002 and operational on January 1, 2003, Cord Partners, a Cord Blood America company, has established itself as a platinum standard national competitor in the umbilical cord blood storage industry. Cord Partners was founded by Matthew L. Schissler, Chairman and CEO, Stephanie Schissler, former President & COO and who is a consultant to the company, and Laura Fitzpatrick, former Vice President of Strategic Relations.
Cord Blood America, Inc. is a publicly traded company. Its common stock trades on the Nasdaq OTC Bulletin Board, under the symbol: CBAI.
Cord Partners was founded on a simple principle: The families who seek stem cell preservation should never have to work to achieve this. By bundling such services as medical kit preparation, medical courier arrangement, 24/7 customer service, easy enrollment, and one price for all services, we feel an unparalleled commitment to our clients, and have the foundation for providing the highest quality stem cell preservation available.
|
